Fumaric Acid

Fumaric Acid

SCHEMBL4500295

NC1CCN(Cc2ccccc2C(F)(F)F)C1.O=C(O)/C=C/C(=O)O

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
KMT2A known ✓ Q03164 3/20 0.49
MEN1 known ✓ O00255 2/20 0.49
SLC6A2 known ✓ P23975 6/20 0.47
SLC6A4 known ✓ P31645 6/20 0.47
KDM4E B2RXH2 9/20 0.53
ALDH1A1 P00352 7/20 0.52
ATM Q13315 3/20 0.51
TDP1 Q9NUW8 3/20 0.51
NPSR1 Q6W5P4 2/20 0.51
GAA P10253 1/20 0.51
MAPT P10636 1/20 0.51
SIGMAR1 Q99720 1/20 0.48
RECQL P46063 1/20 0.46
PARP1 P09874 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL4500298 1.00 KDM4E (0.53) KDM4EALDH1A1ATMTDP1NPSR1
SCHEMBL4488404 0.89 KDM4E (0.56) KDM4EALDH1A1ATMTDP1NPSR1
SCHEMBL6944191 0.81 KDM4E (0.63) KDM4EALDH1A1ATMTDP1NPSR1
SCHEMBL29783956 0.76 KDM4E (0.70) KDM4EALDH1A1ATMTDP1NPSR1
Fumaric Acid SCHEMBL6187286 0.75 SIGMAR1 (0.54) KDM4EALDH1A1ATMTDP1NPSR1
Fumaric Acid SCHEMBL6187283 0.75 SIGMAR1 (0.54) KDM4EALDH1A1ATMTDP1NPSR1
Trifluoroacetic Acid SCHEMBL19613524 0.74 DRD2 (0.49) ALDH1A1KMT2AMEN1SIGMAR1
Trifluoroacetic Acid SCHEMBL19613522 0.74 DRD2 (0.49) ALDH1A1KMT2AMEN1SIGMAR1
Formic Acid SCHEMBL28291907 0.73 KDM4E (0.54) KDM4EALDH1A1ATMTDP1NPSR1
SCHEMBL15859937 0.73 KDM4E (0.63) KDM4EALDH1A1ATMTDP1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7619096-B2 3-Aminopyrrolidines as inhibitors of monoamine uptake ELI LILLY AND COMPANY (US) 2009-11-17 US disclosed
US-20060270713-A1 3-Aminopyrrolidines as inhibitors of monoamine uptake ELI LILLY AND COMPANY 2006-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060270713-A1 3-Aminopyrrolidines as inhibitors of monoamine uptake SLC6A2, SLC6A3, SLC18A2 KMT2A 3131/4885MEN1 1606/4885SLC6A2 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.